Covid-19 survivors who have moderate or severe obesity may have a greater risk of experiencing long-term consequences of the disease, compared to the patients who do not have obesity, showed an observational study....
Like HIV and hepatitis, Covid-19 cannot transmit to the new born babies even if the mother had tested positive for the deadly virus, as around 250 nCoV positive women were found to have delivered healthy babies in Tripura, doctors and experts said....
Chile has temporarily suspended the Oxford-AstraZeneca vaccine against Covid-19 for people under 45 years of age, after an "adverse event" was reported in a person immunised with the jab....
People fully vaccinated with two doses of the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant (B16172) when compared to the original strain, according to new laboratory data that supports Pfizer's plans to deliver booster shots in Autumn....
The B.1.6172 coronavirus variant, also known as Delta, has become the "dominant" strain in the UK, according to the Public Health England (PHE)....
Riding on strong vaccination numbers at home where more than 63 per cent of American adults have received at least one dose, US President Joe Biden announced on Thursday the US will donate 75 per cent of its unused Covid-19 vaccine stockpile to the United Nations-led COVAX global vaccine program which has delivered less than 80 million doses so far....
The World Bank Group and the International Monetary Fund (IMF) on Thursday called on countries anticipating excess vaccine supplies in the coming months to release their surplus doses and options as soon as possible to developing countries. ...
More than 26.58 million people aged 18 or older, representing 50.6 per cent of the adult population in France, have received the first Covid-19 vaccine shot as the inoculation program continues at a faster pace, according to data from the Health Ministry. ...
In another landmark move in the fight against Covid-19 pandemic, the Central government has booked 30 crore doses of another Made-in-India vaccine to be manufactured by Hyderabad-based Biological-E's Covid vaccine, which is still in final phase of clinical trials....
The Covax programme has received $2.4 billion aid for providing equitable vaccinations in low-income countries....
